Background: Human immunodeficiency virus (HIV) infection and antiretroviral therapy (ART) are associated with metabolic disturbances, including dyslipidaemia and increased cardiovascular risk. Aim: This study evaluated lipid profile alterations and atherogenic cardiovascular risk...
Open access
Research Article10.9734/ISRR/2026/v15i1198
Background: Dyslipidemia is a recognized metabolic complication among people living with HIV receiving highly active antiretroviral therapy (HAART). As survival improves with long-term antiretroviral treatment, lipid abnormalities are becoming increasingly important contributors...
Open access
Research Article10.9734/ajrcd/2026/v8i1155
Human immunodeficiency virus (HIV) infection remains a significant global health challenge. While the introduction of highly active antiretroviral therapy (HAART) has greatly improved survival and quality of life, it has also been associated with metabolic complications, includin...
Open access
Research Article10.9734/ajcr/2026/v9i1364
Background: Pregnancy is associated with significant physiological changes in renal function, which influence the interpretation of biochemical markers. However, population-specific data on renal biomarkers and derived indices among pregnant women in sub-Saharan Africa remain lim...
Open access
Research Article10.9734/ajrn/2026/v9i1120
Background: Serum uric acid has emerged as a clinically relevant biomarker in pregnancy due to its association with renal function, oxidative stress, and hypertensive disorders such as preeclampsia. The uric acid–creatinine ratio has been proposed as a more sensitive indicator of...
Open access
Research Article10.9734/ijanr/2026/v9i194
Gravidity, or the number of pregnancies a woman has had, is linked to a number of biochemical alterations, including changes in cardiovascular parameters. These modifications may increase the likelihood of cardiovascular disease in this population. The aim of this research was t...
Open access
Research Article10.9734/bji/2022/v26i230167